218 related articles for article (PubMed ID: 9098206)
1. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
[TBL] [Abstract][Full Text] [Related]
3. FDG-SPECT: correlation with FDG-PET.
Martin WH; Delbeke D; Patton JA; Hendrix B; Weinfeld Z; Ohana I; Kessler RM; Sandler MP
J Nucl Med; 1995 Jun; 36(6):988-95. PubMed ID: 7769457
[TBL] [Abstract][Full Text] [Related]
4. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
5. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG.
Delbeke D; Videlefsky S; Patton JA; Campbell MG; Martin WH; Ohana I; Sandler MP
J Nucl Med; 1995 Nov; 36(11):2110-9. PubMed ID: 7472607
[TBL] [Abstract][Full Text] [Related]
6. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
7. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
9. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
[TBL] [Abstract][Full Text] [Related]
10. Present assessment of myocardial viability by nuclear imaging.
Saha GB; MacIntyre WJ; Brunken RC; Go RT; Raja S; Wong CO; Chen EQ
Semin Nucl Med; 1996 Oct; 26(4):315-35. PubMed ID: 8916320
[TBL] [Abstract][Full Text] [Related]
11. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
[TBL] [Abstract][Full Text] [Related]
13. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
[TBL] [Abstract][Full Text] [Related]
14. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
Martin WH; Delbeke D; Patton JA; Sandler MP
Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
[TBL] [Abstract][Full Text] [Related]
15. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
[TBL] [Abstract][Full Text] [Related]
16. PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose.
Schraml FV; Driver DR; Randolph T; Silverman ED
J Nucl Med Technol; 1997 Dec; 25(4):272-4. PubMed ID: 9438929
[TBL] [Abstract][Full Text] [Related]
17. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
18. [18Fluoro-FDG SPECT for the demonstration of hibernating myocardium: an interim account].
Alexander C; Schaefer A; Trampert L; Oberhausen E; Kirsch CM; Berberich R
Nuklearmedizin; 1997 Jun; 36(4):125-30. PubMed ID: 9289698
[TBL] [Abstract][Full Text] [Related]
19. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
[TBL] [Abstract][Full Text] [Related]
20. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
